GE Announces Sale Of Its Biopharma Business For $21 Billion
As a part of its restructuring plan and to further focus completely on its core business some of the peripheral businesses are being sold off by the once sprawling conglomerate General Electric. The company announced the selling off its biopharma business to Danaher Corp. for $21.4 billion. Last year, revenue of $3 billion was generated…









